Zimmer Persona Revision Femoral Distal Augment Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Zimmer, Inc. is recalling 12 units of the Persona Revision Trabecular Metal Femoral Distal Augment due to a packaging error.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 5, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Firm received a complaint with no clinical impact in which a posterior augment was found within the distal augment package.
Which Products Are Affected
Brand Name: Persona Revision. Product Name: Persona Revision Trabecular Metal Femoral Distal Augment. Model/Catalog Number: 42-5572-066-10. Lot Code: 66232947. UDI-DI: (01)00889024561014(17)331103(10)66232947. 12 units affected. Recall Number: Z-2578-2026. Classification: Class II. Recall initiation date: 20260511.
What You Should Do
Refer to the recalling firm for further information regarding the affected consignees.
Why This Matters
This is an ongoing Class II recall involving 12 units distributed in the United States.
Source
FDA recall Z-2578-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (742 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 5, 2026.
Frequently Asked Questions
Common questions about this FDA recall.